TY - JOUR T1 - Late-breaking abstract: Impact of asthma, allergic rhinitis, COPD and rhinosinusitis on healthcare resource utilization in Asia JF - European Respiratory Journal JO - Eur Respir J VL - 44 IS - Suppl 58 SP - P1814 AU - Shalini Bagga AU - Sang-Heon Cho AU - Aloke Gopal Ghoshal AU - Abdul Razak Bin Abdul Muttalif AU - Horng-Chyuan Lin AU - Sanguansak Thanaviratananich AU - Rab Faruqi AU - Alan Brnabic AU - Francis Dehle AU - Wang De Yun Y1 - 2014/09/01 UR - http://erj.ersjournals.com/content/44/Suppl_58/P1814.abstract N2 - Background: There is a lack of healthcare resource utilization (HCRU) data on respiratory diseases in Asia.Objectives: Asia-Pacific Burden of Respiratory Diseases (APBORD) is a cross-sectional, observational study of burden of disease of Asthma, Allergic Rhinitis (AR), COPD, and Rhinosinusitis in adults across India, Korea, Malaysia, Singapore, Taiwan, and Thailand.Methods: All patients presenting to a physician with primary diagnosis of interest and who consented were enrolled. Of 13,902 participants screened, the study enrolled 5250 participants - Asthma (13.5%), AR (14.0%), COPD (4.9%) or Rhinosinusitis (5.4%). Participants completed a survey of respiratory symptoms, HCRU (office visits, ER visits, hospitalization, medication use, etc.) and Work Productivity and Activity Impairment.Results: HCRU in four weeks before the visit was greater for participants with cough as main reason for their current medical visit compared to those presenting with a different primary symptom. More participants with cough visited a GP (31.5% vs 19.0%), emergency department (2.4% vs 1.4%) and less visited a specialist (21.4% vs 27.5%). Patients with primary diagnosis of COPD reported highest medication use (91%), followed by Asthma (87%), AR (71%) and Rhinosinusitis (67%). For all patients during the last seven days prior to visit, mean (SD) impairment at work was 33.9% (27.28%), work time missed 5.1% (14.81%), and overall productivity loss 36.0% (28.31%).Conclusions: Asthma, AR, COPD, and Rhinosinusitis have a major impact on HCRU and work productivity in Asia. Timely, effective management of these diseases has the potential to reduce burden and save already scarce healthcare resources. ER -